Latest News
Amazon Shares Gain as Supreme Court Overturns Tariffs, Focus Shifts to Nvidia AI Spending
Amazon shares advanced 2.6% on Friday following a Supreme Court decision to overturn former President Trump's global tariffs. Market attention turns to Nvidia's upcoming earnings report for signals on artificial intelligence investment trends.
Nvidia Shares Gain on Reported OpenAI Stake Ahead of Key Earnings
Nvidia shares advanced in extended trading following a report the chipmaker is nearing a $30 billion investment in OpenAI. All eyes are on the company's fiscal fourth-quarter earnings report due next week.
FTSE 100 Rises on US Tariff Ruling, UK Data; BoE Decision Looms
London's FTSE 100 index closed higher, lifted by a US court decision striking down Trump-era tariffs and better-than-expected UK retail sales. Defence shares were the week's top performers.
Tesla Cybertruck Price Cuts Meet Legal Headwinds, Shares Stagnant
Tesla stock showed minimal movement following the announcement of a limited-time Cybertruck price reduction and a federal judge upholding a major Autopilot-related verdict. Investors are weighing demand stimulus against margin and legal risks.
Visa Advances in Argentina Amid Mexico Regulatory Setback
Visa shares gained 0.8% after announcing an acquisition in Argentina, though expansion plans in Mexico faced a regulatory hurdle.
Coinbase Gains on Bitcoin Rally Amid Operational Scrutiny
Coinbase shares advanced Friday alongside Bitcoin, though a display issue affecting decentralized exchange token balances and a broker's price target cut tempered sentiment. The exchange continues navigating weak trading volumes and a push toward diversification.
Carvana Shares Recover After Steep Post-Earnings Decline
Carvana shares rose roughly 2% Friday, recovering some ground after a sharp post-earnings sell-off driven by elevated vehicle reconditioning expenses and retail depreciation.
Figma Shares Gain on Raised Revenue Outlook, AI Pricing Shift Looms
Figma shares advanced after the company raised its 2026 revenue target and outlined a March implementation of AI usage caps, prompting some Wall Street firms to lower price targets.
J&J Shares Dip Amid $20B Orthopedics Unit Sale Talks, New Facility Investment
Johnson & Johnson shares fell following reports the company is exploring a sale of its DePuy Synthes orthopedics business for around $20 billion. The healthcare giant also committed over $1 billion to a new cell-therapy manufacturing plant in Pennsylvania.